Search

Your search keyword '"Wu, Yibo"' showing total 8 results
Start Over Author "Wu, Yibo" Journal blood
8 results on '"Wu, Yibo"'

2. Double Filtration Plasmapheresis for Desensitization during Haploidentical Stem Cell Transplantation in Patients with Positive Donor-Specific Anti-HLA Antibodies

Author

Liu, Lizhen, primary, Ji, Xinyu, additional, Zhu, Panpan, additional, Yang, Luxin, additional, Shi, Jimin, additional, Zhao, Yanmin, additional, Lai, Xiaoyu, additional, Yu, Jian, additional, Fu, Huarui, additional, Ye, Yishan, additional, Wu, Yibo, additional, Huang, He, additional, and Luo, Yi, additional

Published
2022
Full Text
View/download PDF

3. Muticenter Retrospective Comparable Study of Prophylactic Versus Preemptive Modified Donor Lymphocyte Infusion for Patients with High-Risk Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Author

Yang, Luxin, primary, Lai, Xiaoyu, additional, Yang, Ting, additional, Lu, Ying, additional, Liu, Lizhen, additional, Shi, Jimin, additional, Zhao, Yanmin, additional, Wu, Yibo, additional, Chen, Yi, additional, Yu, Jian, additional, Xiao, Haowen, additional, Ouyang, Guifang, additional, Ren, Jinhua, additional, Cao, Junjie, additional, Hu, Yongxian, additional, Tan, Yamin, additional, Cai, Zhen, additional, Huang, He, additional, and Luo, Yi, additional

Published
2022
Full Text
View/download PDF

8. Reduced Intensity Condition of ATG Based Haploidentical Hematopoietic Stem Cell Transplantation in Elderly or Unfit Patients

Author

Pan, Mingyue, Wu, Yibo, Yang, Luxin, Shi, Jimin, Lai, Xiaoyu, Liu, Lizhen, Zhao, Yanmin, Yu, Jian, Jie, Sun, Zheng, Weiyan, Wu, Wenjun, Cai, Zhen, Huang, He, and Luo, Yi

Abstract

Aims: Reduced-intensity conditioning (RIC) regimens allogeneic hematopoietic stem cell transplantation (HSCT) was developed for older patients or those with poor functional status. Haploidentical donor was appropriate alternative donor for patients without matched donors or patients with emergency disease state. However, there was few studies report the outcomes of RIC regimen of ATG based haploidentical HSCT. The selection of the appropriate RIC regimen based on age and comorbidities in ATG based haploidentical HSCT remains poorly described. To investigate the safety and efficacy of RIC regimen ATG-based haploidentical HSCT in elderly or unfit patients. Additionally, to explore the potential factors that impact the prognosis of RIC regimen of ATG based haploidentical HSCT.

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results